Hair Loss with Levetiracetam in Five Patients with Epilepsy
November 2013
in “
Seizure: European Journal of Epilepsy
”
Studysummary This study reports that hair loss may be a rare side effect of levetiracetam in epilepsy patients and appears reversible upon dose reduction or cessation.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document described a study involving five epilepsy patients who experienced hair loss after beginning treatment with levetiracetam (LEV). The group consisted of four females and one male, with varying types of epilepsy. Hair loss was observed within two months of starting LEV, with three patients on monotherapy and two on combination therapy. Despite the side effect, none stopped LEV treatment, though one had their dose lowered. The study concluded that hair loss is a possible but rare side effect of LEV, which may be reversible with dose reduction or discontinuation. It emphasized the importance of awareness among patients and clinicians regarding this side effect and the consideration of dose adjustments or alternative treatments if necessary.
